Drug treatments in Alzheimer’s disease
Robert Briggs, Sean P Kennelly and Desmond O'Neill
DOI: https://doi.org/10.7861/clinmedicine.16-3-247
Clin Med June 2016 Robert Briggs
ACentre for Ageing, Neuroscience and the Humanities, Trinity Centre for Health Sciences, Tallaght Hospital, Dublin, Ireland
Roles: research fellow
Sean P Kennelly
BCentre for Ageing, Neuroscience and the Humanities, Trinity Centre for Health Sciences, Tallaght Hospital, Dublin, Ireland
Roles: consultant geriatrician and stroke physician
Desmond O'Neill
CCentre for Ageing, Neuroscience and the Humanities, Trinity Centre for Health Sciences, Tallaght Hospital, Dublin, Ireland
Roles: consultant geriatrician and professor of medical gerontology
Article Tools
Drug treatments in Alzheimer’s disease
Robert Briggs, Sean P Kennelly, Desmond O'Neill
Clinical Medicine Jun 2016, 16 (3) 247-253; DOI: 10.7861/clinmedicine.16-3-247
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- Characterizing Treatment Non-responders vs. Responders in Completed Alzheimers Disease Clinical Trials
- Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities
- Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimers disease therapy
- Decreased Levels of Blood AMPK{alpha}1 but not AMPK{alpha}2 Isoform in Patients with Mild Cognitive Impairment and Alzheimers Disease: A Pilot Study
- Modulation of Amyloid States by Molecular Chaperones